ICAR has developed India's first fully annotated T2T reference genome of pigeonpea, paving the way for faster breeding of climate-resilient, high-yielding varieties
BIRAC has received nearly 200 applications under the RDI fund and shortlisted 7-8 biotech startups as demand rises for deep-tech and innovation financing
With a record wave of deal-making, IPO activity and fresh venture capital flowing into Chinese biotech in 2024-25, prices of lab monkeys used for drug testing are rising again
GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive dialogue after scientific review can effectively build trust and transparency
NITI Aayog suggests developing herbicide-tolerant pulses varieties and including pulses in welfare programs like PDS to boost domestic production and ensure self-sufficiency in pulses production
Shares of Anthem Biosciences surged 9 per cent to ₹820 on the BSE in Thursday's intra-day trade amid heavy volumes after reporting a strong earnings for the quarter ended June 2025.
Driven by state strategy, rapid innovation, and industrial dominance, China's surge in EVs, renewables, and biotech is not just disrupting industries, it's rewriting the global technological order
Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough designations as they gain confidence in China's biotech innovation
The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets
The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development